<p>Bio-Rad Laboratories, Inc.（纽约证券交易所代码：BIO.B - 获取免费报告）在周五的交易量有所上升。交易期间共交易了 380 股，较前一交易日的 300 股增加了 27%。该股票最后交易价格为 255.54 美元，之前收盘价为 258.46 美元。</p>
<p>获取 <strong>Bio-Rad Laboratories</strong> 的提醒：</p>
<h2>Bio-Rad Laboratories 股票下跌 1.1%</h2>
<p>该公司的 50 日移动平均价格为 276.18 美元，200 日移动平均价格为 294.91 美元。公司市值为 69 亿美元，市盈率为 42.10，贝塔值为 0.96。公司的债务与股本比率为 0.12，速动比率为 2.37，流动比率为 3.21。</p>
<p>Bio-Rad Laboratories（纽约证券交易所代码：BIO.B - 获取免费报告）于 4 月 30 日（星期四）发布了季度财报。公司报告该季度每股收益为 1.89 美元。Bio-Rad Laboratories 的净利润率为 6.52%，股本回报率为 3.56%。</p>
<h2>Bio-Rad Laboratories 公司简介</h2>
<p>（获取免费报告）</p>
<p>Bio-Rad Laboratories, Inc 是一家全球领先的创新产品和系统提供商，服务于生命科学研究和临床诊断市场。该公司通过两个主要部门运营：生命科学部门，提供用于研究应用的仪器、耗材和软件；临床诊断部门，提供用于血型鉴定、免疫学和分子检测的质量控制材料和试剂系统。Bio-Rad 的产品组合支持广泛的应用，包括蛋白质分析、基因表达、细胞生物学和数字 PCR。</p>
<p>在生命科学部门，Bio-Rad 开发和销售电泳和成像系统、色谱仪器、实验室耗材和简化实验工作流程的软件平台等技术。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过 Bio-Rad Laboratories</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Bio-Rad Laboratories 吗？</h2>
<p>在你考虑 Bio-Rad Laboratories 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Bio-Rad Laboratories 并不在名单上。</p>
<p>虽然 Bio-Rad Laboratories 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

Bio-Rad实验室-B

<p>Bio-Rad 实验室（NYSE:BIO.B）在周五的交易量增加了 27%，共交易了 380 股。股价下跌了 1.1%，至 255.54 美元，较前一交易日的 258.46 美元有所下降。该公司的市值为 69 亿美元，市盈率为 42.10，净利润率为 6.52%。分析师目前对 Bio-Rad 的评级为持有，但建议其他股票可能是更好的投资选择</p>

<p>Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) saw an uptick in trading volume on Friday . 380 shares were traded during trading, an increase of 27% from the previous session's volume of 300 shares.The stock last traded at $255.54 and had previously closed at $258.46.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories, Inc.（纽约证券交易所代码：BIO.B - 获取免费报告）在周五的交易量有所上升。交易期间共交易了 380 股，较前一交易日的 300 股增加了 27%。该股票最后交易价格为 255.54 美元，之前收盘价为 258.46 美元。</p>
</div><p>Get <strong>Bio-Rad Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Bio-Rad Laboratories</strong> 的提醒：</p>
</div><h2>Bio-Rad Laboratories Stock Down 1.1%</h2>
<div class="lb-trans"><h2>Bio-Rad Laboratories 股票下跌 1.1%</h2>
</div><p>The firm's 50-day moving average price is $276.18 and its two-hundred day moving average price is $294.91. The firm has a market cap of $6.90 billion, a PE ratio of 42.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.37 and a current ratio of 3.21.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 276.18 美元，200 日移动平均价格为 294.91 美元。公司市值为 69 亿美元，市盈率为 42.10，贝塔值为 0.96。公司的债务与股本比率为 0.12，速动比率为 2.37，流动比率为 3.21。</p>
</div><p>Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.89 EPS for the quarter. Bio-Rad Laboratories had a net margin of 6.52% and a return on equity of 3.56%.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories（纽约证券交易所代码：BIO.B - 获取免费报告）于 4 月 30 日（星期四）发布了季度财报。公司报告该季度每股收益为 1.89 美元。Bio-Rad Laboratories 的净利润率为 6.52%，股本回报率为 3.56%。</p>
</div><h2>Bio-Rad Laboratories Company Profile</h2>
<div class="lb-trans"><h2>Bio-Rad Laboratories 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad's product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories, Inc 是一家全球领先的创新产品和系统提供商，服务于生命科学研究和临床诊断市场。该公司通过两个主要部门运营：生命科学部门，提供用于研究应用的仪器、耗材和软件；临床诊断部门，提供用于血型鉴定、免疫学和分子检测的质量控制材料和试剂系统。Bio-Rad 的产品组合支持广泛的应用，包括蛋白质分析、基因表达、细胞生物学和数字 PCR。</p>
</div><p>In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.</p>
<div class="lb-trans"><p>在生命科学部门，Bio-Rad 开发和销售电泳和成像系统、色谱仪器、实验室耗材和简化实验工作流程的软件平台等技术。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Bio-Rad Laboratories</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Bio-Rad Laboratories</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bio-Rad Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Bio-Rad Laboratories 吗？</h2>
</div><p>Before you consider Bio-Rad Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Bio-Rad Laboratories 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Bio-Rad Laboratories 并不在名单上。</p>
</div><p>While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Bio-Rad Laboratories 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Bio-Rad Lab-B（NYSE:BIO.B）交易量强劲 - 你是否应该购买？